Axsome Therapeutics Inc

Software Data Engineer

United States

Not SpecifiedCompensation
Senior (5 to 8 years), Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, AI & Data ScienceIndustries

Position Overview

  • Location Type: Remote
  • Employment Type: Full-Time
  • Salary: Not provided This role focuses on building and optimizing data pipelines for AI model training in drug discovery. The individual will collaborate with various teams to improve data processing workflows, storage infrastructure, and overall system reliability. Preference is given to candidates on the East Coast or UK.

Requirements

  • Experience: Minimum of 8 years of related experience with a Bachelor’s degree; or 6 years and a Master’s degree; or a PhD with 3 years experience; or equivalent experience.
  • ETL Design: Proven ability to design flexible, maintainable ETL (Extract, Transform, Load) systems.
  • Data Pipeline Tools: Experience with data pipeline orchestration tools such as Prefect, Airflow, Argo, Databricks, or Spark.
  • ML Lifecycle Understanding: Understanding of the ML model lifecycle. Prior work with scientific or ML workflows is a plus.
  • Data Scale: Hands-on experience with multi-terabyte scale data processing.
  • AWS Familiarity: Familiarity with AWS. Kubernetes experience is a bonus.
  • Data Lake Technologies: Knowledge of data lake technologies such as Parquet, Iceberg, AWS Glue, etc.
  • Python Skills: Strong Python software engineering skills.
  • Mindset: Pragmatic mindset – able to evaluate tradeoffs and find solutions that empower ML researchers to move quickly.

Responsibilities

  • Data Pipeline Design & Improvement: Design and improve data pipelines that process large, multi-modal datasets from various internal and external sources into training datasets for AI models.
  • Data Storage Evolution: Evolve our data storage layer to support analytics, schema evolution, reproducibility, and efficient data access.
  • Workflow Optimization: Collaborate with ML engineers to improve the performance and reliability of Python-based data processing workflows.
  • Software System Development: Collaborate on the creation, testing, and maintenance of software systems.
  • Code Review: Conduct code review for pull requests in adjoining areas.
  • Best Practices: Maintenance of and mentorship in software best practices, including version control, testing, and documentation.
  • Communication: Clear oral communication of work in meetings and company demos, at a level suited to the audience.

Application Instructions

Not provided in the job description.

Company Information

About Iambic Therapeutics: Founded in 2019 and headquartered in San Diego, California, Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to cl

Skills

ETL Design
Data pipeline orchestration (Prefect, Airflow, Argo, Databricks, Spark)
ML lifecycle understanding
Multi-terabyte data processing
AWS
Kubernetes
Data lake technologies (Parquet, Iceberg, AWS Glue)
Python

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI